Inventor · name-matched record
ERLANDER MARK
0 granted patents·2 pending applications·0 citations·filing 2023–2025
Technology areasA61K
Files withCARDIFF ONCOLOGY INC2
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
2 records- 0168US2026069596A1Use of plk1 inhibitor as monotherapy and in combination with cetuximab in treating ras wild-type colorectal cancerCARDIFF ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 0256US2026076970A1Cancer treatment using mtdp inhibitors and plk1 inhibitorsCARDIFF ONCOLOGY INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ERLANDER MARK files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →